Zydus Cadila gets approval for muscle spasticity drug
Zydus Cadila gets approval for muscle spasticity drug

Zydus Cadila gets approval for muscle spasticity drug

Nidhi Jani Article rating: 5.0

Baclofen is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease. It works by helping to relax the muscles.

ABB Power bags project from IOCL worth Rs 165 crore
ABB Power bags project from IOCL worth Rs 165 crore

ABB Power bags project from IOCL worth Rs 165 crore

Apurva Joshi Article rating: 2.5

ABB Power Grids has bagged a project worth Rs 165 crore from state-owned refiner Indian Oil Corporation Limited (IOCL) to ensure reliable grid connection at its Barauni refinery in Bihar.

Index trend and stocks in action on April 20, 2020
Index trend and stocks in action on April 20, 2020

Index trend and stocks in action on April 20, 2020

Karan Dsij Article rating: 4.0

The traders should set their eyes on 9,390-9,600 zone on the upside and on the downside, an immediate support is seen around 9,000, followed by 8,800. Stocks in news: Maithan Alloys, Muthoot Finance, Tata Motors, GAIL, Cupid, Cadila Healthcare, TVS Motor.

Markets likely to start on a soft note!
Markets likely to start on a soft note!

Markets likely to start on a soft note!

Karan Dsij Article rating: 5.0

A muted start is expected for Indian markets on Monday as cues from Asian peers are mixed. However, stock specific action is likely to continue. Today, the major focus would be on banking heavyweight-HDFC Bank as it reported its number on weekend. The focus would also be on Infosys as it is scheduled to come out with its Q4 numbers.

Shilpa Medicare gets EIR from USFDA for Raichur API site
Shilpa Medicare gets EIR from USFDA for Raichur API site

Shilpa Medicare gets EIR from USFDA for Raichur API site

Avalokita Pandey Article rating: 3.0

Pharmaceutical company, Shilpa Medicare Ltd, announced today that it has received an establishment inspection report (EIR) from US Food & Drug Administration (USFDA) for the inspection conducted at API manufacturing site in Raichur (Karnataka).

Bank Nifty: Zone of 19,500-19,700 to act as crucial support
Bank Nifty: Zone of 19,500-19,700 to act as crucial support

Bank Nifty: Zone of 19,500-19,700 to act as crucial support

Vinayak Gangule Article rating: 4.2

The key takeaway from Friday’s session was that Bank Nifty closed above its 20-day EMA for the first time in the last 39 trading sessions. Bank Nifty also managed to close above 23.6 per cent Fibonacci retracement level of its prior downward move (32,613.10-16,116.25) decisively.

Bulls take charge as Sensex surges by more than 900 points
Bulls take charge as Sensex surges by more than 900 points

Bulls take charge as Sensex surges by more than 900 points

Geyatee Deshpande Article rating: No rating

Domestic benchmark indices have ended the week on a positive note today as Sensex zoomed by 3.22 per cent which is 986.11 points to be at the level of 31,588.72 while, Nifty went up by 3.05 per cent which is 273.95 points to the level of 9,266.75.

Kotak Mahindra Bank introduces ‘ATM on wheels
Kotak Mahindra Bank introduces ‘ATM on wheels

Kotak Mahindra Bank introduces ‘ATM on wheels

Avalokita Pandey Article rating: 4.2

Indian private banking company, Kotak Mahindra Bank, announced the launch of ‘ATM on wheels’ facility in and around Mumbai amid the nationwide lockdown caused due to the rapid spread of Coronavirus.

Torrent Pharmaceuticals forms bearish engulfing candle
Torrent Pharmaceuticals forms bearish engulfing candle

Torrent Pharmaceuticals forms bearish engulfing candle

Vinayak Gangule Article rating: 3.9

The stock of Torrent Pharmaceuticals Limited has formed a bearish engulfing candlestick pattern on the weekly timeframe. This pattern is considered to be a bearish reversal pattern and usually occurs at the top of an uptrend.

RSS
First21792180218121822184218621872188Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR